不同胰岛素抵抗相关指标作为生物标志物预测2型糖尿病患者外周动脉病变的价值及比较研究
Value and Comparison of Insulin Resistance-Related Indexes as Biomarkers in Predicting Peripheral Artery Disease in Type 2 Diabetes Mellitus
DOI: 10.12677/acm.2026.161314, PDF,    科研立项经费支持
作者: 马 莉, 杜 婧*, 丁玉梅, 刘竞之, 马蓉蓉:宁夏回族自治区人民医院(宁夏医科大学附属自治区人民医院)内分泌科,宁夏 银川
关键词: 胰岛素抵抗胰岛素抵抗相关指标2型糖尿病外周动脉病变Insulin Resistance Insulin Resistance-Related Indexes Type 2 Diabetes Mellitus Peripheral Artery Disease
摘要: 目的:本研究旨在探讨8种胰岛素抵抗(IR)相关指标[三酰甘油与葡萄糖乘积指数(TyG)、三酰甘油葡萄糖体质量指数(TyG-BMI)、三酰甘油–高密度脂蛋白胆固醇指数(TG/HDL-C)、胰岛素抵抗代谢指数(METS-IR)、稳态模型评估胰岛素抵抗指数(HOMA-IR)、非高密度脂蛋白胆固醇–高密度脂蛋白胆固醇指(Non-HDL-C/HDL-C)、脂质心血管指数(LCI)、胆固醇指数(CI)]作为生物标志物预测2型糖尿病(T2DM)患者外周动脉病变(PAD)的价值,并比较其预测效能。方法:回顾性收集2023年1月至2024年12月于宁夏回族自治区人民医院内分泌科住院期间收住的1055例T2DM患者临床资料,根据多普勒超声结果分为PAD组(420例)和非PAD组(635例)。采用统计学方法比较两组一般资料及生化指标的差异,通过Logistic回归分析IR相关指标与PAD的关联,运用ROC曲线、重分类改善指标(NRI)及综合判别改善指标(IDI)评估各指标的预测效能。结果:结果显示,PAD组的8种IR相关指标水平均显著高于非PAD组(P < 0.05),且与PAD风险呈正相关及剂量–反应关系(P < 0.05)。ROC曲线分析结果显示,TG/HDL-C指数的预测效能最佳(AUC = 0.689),而TyG指数的灵敏度最高(87.4%)。NRI和IDI分析表明,TyG指数在提升模型预测效能上表现最优。结论:TG/HDL-C指数和TyG指数可作为预测T2DM患者发生PAD的优质生物标志物,其中TG/HDL-C指数因检测便捷、效能突出,更适合在基层医疗机构推广应用。
Abstract: Objective: The purpose of this study is to explore the value of eight insulin resistance (IR)-related indicators [triglyceride-glucose index (TyG), triglyceride-glucose-body mass index (TyG-BMI), triglyceride-high-density lipoprotein cholesterol index (TG/HDL-C), metabolic score for insulin resistance (METS-IR), homeostasis model assessment of insulin resistance (HOMA-IR), non-high-density lipoprotein cholesterol-high-density lipoprotein cholesterol index (Non-HDL-C/HDL-C), lipid cardiovascular index (LCI), and cholesterol index (CI)] as biomarkers in predicting peripheral artery disease (PAD) in patients with type 2 diabetes mellitus (T2DM), and to compare their predictive efficacy. Methods: The clinical data of 1055 T2DM patients who were hospitalized in the Endocrinology Department of Ningxia Uygur Autonomous Region People’s Hospital from January 2023 to December 2024 were retrospectively collected. According to the results of vascular color Doppler ultrasound, the patients were divided into the PAD group (420 cases) and the non-PAD group (635 cases). Statistical methods were used to analyze the differences in general data and biochemical indicators between the two groups. Logistic regression was employed to explore the association between IR-related indicators and PAD. ROC curves, NRI and IDI were used to evaluate the predictive efficacy of each indicator. Results: The results showed that the levels of the 8 IR-related indicators in the PAD group were significantly higher than those in the non-PAD group (P < 0.05), and were positively correlated with and showed a dose-response relationship with the risk of PAD (P < 0.05). In the ROC curve analysis, the TG/HDL-C index had the best predictive efficacy (AUC = 0.689), and the TyG index had the highest sensitivity (87.4%). The NRI and IDI analyses indicated that the TyG index performed the best in improving the predictive efficacy of the model. Conclusion: TG/HDL-C index and TyG index can be used as high quality biomarkers for predicting PAD in patients with T2DM. TG/HDL-C index is more suitable for popularization and application in primary medical institutions because of its convenient detection and outstanding efficacy.
文章引用:马莉, 杜婧, 丁玉梅, 刘竞之, 马蓉蓉. 不同胰岛素抵抗相关指标作为生物标志物预测2型糖尿病患者外周动脉病变的价值及比较研究[J]. 临床医学进展, 2026, 16(1): 2527-2544. https://doi.org/10.12677/acm.2026.161314

参考文献

[1] Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B.B., et al. (2023) Erratum to “IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045” [Diabetes Res. Clin. Pract. 183 (2022) 109119]. Diabetes Research and Clinical Practice, 204, Article ID: 110945. [Google Scholar] [CrossRef] [PubMed]
[2] Zhou, Y.C., Liu, J.M., Zhao, Z.P., et al. (2025) The National and Provincial Prevalence and Non-Fatal Burdens of Diabetes in China from 2005 to 2023 with Projections of Prevalence to 2050. Military Medical Research, 12, Article No. 28. [Google Scholar] [CrossRef] [PubMed]
[3] American Diabetes Association (2019) 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes—2020. Diabetes Care, 43, S7-S13. [Google Scholar] [CrossRef] [PubMed]
[4] 赵培. 下肢动脉血管彩色多普勒超声检查在糖尿病周围血管病变中的应用价值研究[J]. 中国社区医师, 2019, 35(36): 127-129.
[5] Rehman, Z.U. and Ram, N. (2023) Peripheral Arterial Disease (PAD) in Diabetics: Diagnosis and Management—A Narrative Review. Journal of the Pakistan Medical Association, 73, 621-626. [Google Scholar] [CrossRef] [PubMed]
[6] Hur, K.Y., Jun, J.E., Choi, Y.J., Lee, Y., Kim, D.J., Park, S.W., et al. (2018) Color Doppler Ultrasonography Is a Useful Tool for Diagnosis of Peripheral Artery Disease in Type 2 Diabetes Mellitus Patients with Ankle-Brachial Index 0.91 to 1.40. Diabetes & Metabolism Journal, 42, 63-73. [Google Scholar] [CrossRef] [PubMed]
[7] Singh, A., Shadangi, S., Gupta, P.K. and Rana, S. (2025) Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies. Comprehensive Physiology, 15, e70003. [Google Scholar] [CrossRef] [PubMed]
[8] Lu, Y., Wang, W., Liu, J., Xie, M., Liu, Q. and Li, S. (2023) Vascular Complications of Diabetes: A Narrative Review. Medicine, 102, e35285. [Google Scholar] [CrossRef] [PubMed]
[9] Paneni, F., Beckman, J.A., Creager, M.A. and Cosentino, F. (2013) Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I. European Heart Journal, 34, 2436-2443. [Google Scholar] [CrossRef] [PubMed]
[10] American Diabetes Association (2003) Peripheral Arterial Disease in People with Diabetes. Diabetes Care, 26, 3333-3341. [Google Scholar] [CrossRef] [PubMed]
[11] Thiruvoipati, T., Kielhorn, C.E. and Armstrong, E.J. (2015) Peripheral Artery Disease in Patients with Diabetes: Epidemiology, Mechanisms, and Outcomes. World Journal of Diabetes, 6, 961-969. [Google Scholar] [CrossRef] [PubMed]
[12] DeFronzo, R.A., Tobin, J.D. and Andres, R. (1979) Glucose Clamp Technique: A Method for Quantifying Insulin Secretion and Resistance. American Journal of Physiology-Endocrinology and Metabolism, 237, E214-E223. [Google Scholar] [CrossRef] [PubMed]
[13] Ramdas Nayak, V.K., Satheesh, P. and Shenoy, M.T. (2022) Triglyceride Glucose (TyG) Index: A Surrogate Biomarker of Insulin Resistance. Journal of the Pakistan Medical Association, 72, 986-988. [Google Scholar] [CrossRef] [PubMed]
[14] Yuan, Y., Sun, W. and Kong, X. (2022) Comparison between Distinct Insulin Resistance Indices in Measuring the Development of Hypertension: The China Health and Nutrition Survey. Frontiers in Cardiovascular Medicine, 9, Article ID: 912197. [Google Scholar] [CrossRef] [PubMed]
[15] Nur Zati Iwani, A.K., Jalaludin, M.Y., Yahya, A., Mansor, F., Md Zain, F., Hong, J.Y.H., et al. (2022) TG: HDL-C Ratio as Insulin Resistance Marker for Metabolic Syndrome in Children with Obesity. Frontiers in Endocrinology, 13, Article ID: 852290. [Google Scholar] [CrossRef] [PubMed]
[16] Bello-Chavolla, O.Y., Almeda-Valdes, P., Gomez-Velasco, D., Viveros-Ruiz, T., Cruz-Bautista, I., Romo-Romo, A., et al. (2018) METS-IR, a Novel Score to Evaluate Insulin Sensitivity, Is Predictive of Visceral Adiposity and Incident Type 2 Diabetes. European Journal of Endocrinology, 178, 533-544. [Google Scholar] [CrossRef] [PubMed]
[17] Tahapary, D.L., Pratisthita, L.B., Fitri, N.A., Marcella, C., Wafa, S., Kurniawan, F., et al. (2022) Challenges in the Diagnosis of Insulin Resistance: Focusing on the Role of HOMA-IR and Tryglyceride/Glucose Index. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 16, Article ID: 102581. [Google Scholar] [CrossRef] [PubMed]
[18] 王亭. 三酰甘油-葡萄糖指数与2型糖尿病周围血管病变相关性分析[J]. 标记免疫分析与临床, 2021, 28(12): 2045-2049.
[19] 雷丽英. 2型糖尿病患者甘油三酯葡萄糖乘积对糖尿病周围血管病变的评估价值研究[J]. 黑龙江中医药, 2023, 52(6): 382-384.
[20] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 国际内分泌代谢杂志, 2021, 41(5): 482-548.
[21] Aboyans, V., Ricco, J.B., Bartelink, M.L.E.L., Björck, M., Brodmann, M., Cohnert, T., et al. (2018) 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in Collaboration with the European Society for Vascular Surgery (ESVS): Document Covering Atherosclerotic Disease of Extracranial Carotid and Vertebral, Mesenteric, Renal, Upper and Lower Extremity Arteries Endorsed by: The European Stroke Organization (ESO) the Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular surgery (ESVS). European Heart Journal, 39, 763-816.
[22] Gerhard-Herman, M.D., Gornik, H.L., Barrett, C., Barshes, N.R., Corriere, M.A., Drachman, D.E., et al. (2017) AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 135, e726-e779.
[23] Ren, B., Li, B., Pan, T., Zhao, E., Ju, S., Li, X., et al. (2023) Risk Factors for At-Risk Foot and Peripheral Artery Disease among the Population with Diabetes: A Multicommunity-Based Cross-Sectional Study. Diabetes Research and Clinical Practice, 203, Article ID: 110869. [Google Scholar] [CrossRef] [PubMed]
[24] Cai, X., Zhu, Q., Liu, S., Wang, M., Wu, T., Hong, J., et al. (2021) Associations between the Metabolic Score for Insulin Resistance Index and the Risk of Type 2 Diabetes Mellitus among Non-Obese Adults: Insights from a Population-Based Cohort Study. International Journal of General Medicine, 14, 7729-7740. [Google Scholar] [CrossRef] [PubMed]
[25] Diniz, M.d.F.H.S., Beleigoli, A.M.R., Schmidt, M.I., Duncan, B.B., Ribeiro, A.L.P., Vidigal, P.G., et al. (2020) Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) and Metabolic Syndrome at Baseline of a Multicentric Brazilian Cohort: ELSA-Brasil Study. Cadernos de Saúde Pública, 36, e00072120. [Google Scholar] [CrossRef] [PubMed]
[26] Son, D., Lee, H.S., Lee, Y., Lee, J. and Han, J. (2022) Comparison of Triglyceride-Glucose Index and HOMA-IR for Predicting Prevalence and Incidence of Metabolic Syndrome. Nutrition, Metabolism and Cardiovascular Diseases, 32, 596-604. [Google Scholar] [CrossRef] [PubMed]
[27] Duan, M., Zhao, X., Li, S., Miao, G., Bai, L., Zhang, Q., et al. (2024) Metabolic Score for Insulin Resistance (METS-IR) Predicts All-Cause and Cardiovascular Mortality in the General Population: Evidence from NHANES 2001-2018. Cardiovascular Diabetology, 23, Article No. 243. [Google Scholar] [CrossRef] [PubMed]
[28] Xiao, D., Sun, H., Chen, L., et al. (2024) Assessment of Six Surrogate Insulin Resistance Indexes for Predicting Cardiometabolic Multimorbidity Incidence in Chinese Middle-Aged and Older Populations: Insights from the China Health and Retirement Longitudinal Study. Diabetes/Metabolism Research and Reviews, 40, e3764.
[29] Renna, N.F., Lembo, C., Diez, E. and Miatello, R.M. (2013) Role of Renin-Angiotensin System and Oxidative Stress on Vascular Inflammation in Insulin Resistence Model. International Journal of Hypertension, 2013, Article ID: 420979. [Google Scholar] [CrossRef] [PubMed]
[30] Kosmas, C.E., Bousvarou, M.D., Kostara, C.E., Papakonstantinou, E.J., Salamou, E. and Guzman, E. (2023) Insulin Resistance and Cardiovascular Disease. Journal of International Medical Research, 51, 3000605231164548. [Google Scholar] [CrossRef] [PubMed]
[31] 肖露露, 梁永林, 李钦, 等. IRS1/PI3K信号通路在T2DM骨骼肌胰岛素抵抗中的相关研究进展[J]. 实用中医内科杂志, 2023, 37(6): 71-75.
[32] Cho, H., Lai, C., Bonnavion, R., Alnouri, M.W., Wang, S., Roquid, K.A., et al. (2025) Endothelial Insulin Resistance Induced by Adrenomedullin Mediates Obesity-Associated Diabetes. Science, 387, 674-682. [Google Scholar] [CrossRef
[33] Cho, H., Lai, C., Bonnavion, R., Alnouri, M.W., Wang, S., Roquid, K.A., et al. (2025) Endothelial Insulin Resistance Induced by Adrenomedullin Mediates Obesity-Associated Diabetes. Science, 387, 674-682. [Google Scholar] [CrossRef] [PubMed]
[34] Beverly, J.K. and Budoff, M.J. (2019) Atherosclerosis: Pathophysiology of Insulin Resistance, Hyperglycemia, Hyperlipidemia, and Inflammation. Journal of Diabetes, 12, 102-104. [Google Scholar] [CrossRef] [PubMed]
[35] Yecies, J.L., Zhang, H.H., Menon, S., Liu, S., Yecies, D., Lipovsky, A.I., et al. (2011) Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel Mtorc1-Dependent and Independent Pathways. Cell Metabolism, 14, 21-32. [Google Scholar] [CrossRef] [PubMed]
[36] Biddinger, S.B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J.T., Alemán, J.O., Suzuki, R., et al. (2008) Hepatic Insulin Resistance Is Sufficient to Produce Dyslipidemia and Susceptibility to Atherosclerosis. Cell Metabolism, 7, 125-134. [Google Scholar] [CrossRef] [PubMed]
[37] Ji, K.T., Qian, L., Nan, J.L., Xue, Y., Zhang, S., Wang, G., et al. (2015) Ox-LDL Induces Dysfunction of Endothelial Progenitor Cells via Activation of NF-κB. BioMed Research International, 2015, Article ID: 175291. [Google Scholar] [CrossRef] [PubMed]
[38] 刘宏飞, 魏翠英. STAT3信号通路在胰岛素抵抗中的研究进展[J]. 天津医药, 2020, 48(4): 343-347.
[39] Matulewicz, N. and Karczewska-Kupczewska, M. (2016) Insulin Resistance and Chronic Inflammation. Postępy Higieny i Medycyny Doświadczalnej (Online), 70, 1245-1258.
[40] Song, Y., Zhao, Y., Shu, Y., Zhang, L., Cheng, W., Wang, L., et al. (2023) Combination Model of Neutrophil to High-Density Lipoprotein Ratio and System Inflammation Response Index Is More Valuable for Predicting Peripheral Arterial Disease in Type 2 Diabetic Patients: A Cross-Sectional Study. Frontiers in Endocrinology, 14, Article ID: 1100453. [Google Scholar] [CrossRef] [PubMed]
[41] 张言佳, 王颖. 外周血血小板与淋巴细胞比值、中性粒细胞与淋巴细胞比值、单核细胞与淋巴细胞比值及全身免疫炎症指数对2型糖尿病周围神经病变的临床诊断价值[J]. 临床内科杂志, 2025, 42(2): 140-142.
[42] 黄光京, 周安邦, 徐媛媛, 等. 2型糖尿病患者单核细胞-淋巴细胞比值与糖尿病足的相关性[J]. 右江医学, 2023, 51(3): 204-210.
[43] 师佩华. 中性粒细胞/淋巴细胞比值、血小板/淋巴细胞比值和单核细胞/淋巴细胞比值与2型糖尿病合并冠心病的研究[D]: [硕士学位论文]. 锦州: 锦州医科大学, 2024.
[44] Juhan-Vague, I., Morange, P.E. and Alessi, M. (2002) The Insulin Resistance Syndrome: Implications for Thrombosis and Cardiovascular Disease. Pathophysiology of Haemostasis and Thrombosis, 32, 269-273. [Google Scholar] [CrossRef] [PubMed]
[45] Bonner, R., Albajrami, O., Hudspeth, J. and Upadhyay, A. (2020) Diabetic Kidney Disease. Primary Care: Clinics in Office Practice, 47, 645-659. [Google Scholar] [CrossRef] [PubMed]
[46] 苏晓燕, 黄昭穗, 郭琦. TG/HDL-C比值预测2型糖尿病下肢动脉硬化的价值[J]. 临床军医杂志, 2011, 39(5): 881-883.
[47] Raja, V., Aguiar, C., Alsayed, N., Chibber, Y.S., ElBadawi, H., Ezhov, M., et al. (2023) Non-HDL-Cholesterol in Dyslipidemia: Review of the State-of-the-Art Literature and Outlook. Atherosclerosis, 383, Article ID: 117312. [Google Scholar] [CrossRef] [PubMed]
[48] Richter, B., Bongaerts, B. and Metzendorf, M. (2023) Thermal Stability and Storage of Human Insulin. Cochrane Database of Systematic Reviews, 11, CD015385. [Google Scholar] [CrossRef] [PubMed]
[49] Miller, W.G., Thienpont, L.M., Van Uytfanghe, K., Clark, P.M., Lindstedt, P., Nilsson, G., et al. (2009) Toward Standardization of Insulin Immunoassays. Clinical Chemistry, 55, 1011-1018. [Google Scholar] [CrossRef] [PubMed]
[50] Cetin, E.G., Demir, N. and Sen, I. (2020) The Relationship between Insulin Resistance and Liver Damage in Non-Alcoholic Fatty Liver Patients. The Medical Bulletin of Sisli Hospital, 54, 411-415. [Google Scholar] [CrossRef] [PubMed]
[51] Signorelli, S.S., Scuto, S., Marino, E., Xourafa, A. and Gaudio, A. (2019) Oxidative Stress in Peripheral Arterial Disease (PAD) Mechanism and Biomarkers. Antioxidants, 8, Article No. 367. [Google Scholar] [CrossRef] [PubMed]
[52] Mocciaro, G. and Gastaldelli, A. (2022) Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction. In: Eckel, J. and Clément, K., Eds., Handbook of Experimental Pharmacology, Springer International Publishing, 145-164. [Google Scholar] [CrossRef] [PubMed]